Miriam Carmela Dinatale, DO

Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.

None Reported

None Reported

Use of selective serotonin reuptake inhibitors (SSRIs) in women delivering liveborn infants and other women of child-bearing age within the U.S. Food and Drug Administration's Mini-Sentinel Program
Archvies of Womens Mental Health
Date: 05 2016
link.springer.com/article/10.1007%2Fs00737-016-0637-1

Medication Use During Pregnancy and Lactation: Introducing the Pregnancy and Lactation Labeling Rule
Pediatric Allergy, Immunology, and Pulmonology
Volume: 30
Date: 06 2017
https://www.liebertpub.com/doi/full/10.1089/ped.2017.0772

Clinicians' Perspective of the New Pregnancy and Lactation Labeling Rule (PLLR): Results from an AAAAI/FDA Survey
J Allergy Clin Immunol Pract.
Date: 02 2019

Validity of Diagnosis and Procedure Codes for Identifying Neural Tube Defects in Infants.
Pharmacoepidemiology and Drug Safety.
Volume: 29
Date: 11 2020
https://pubmed.ncbi.nlm.nih.gov/32929845/

The Importance of Clinical Research in Pregnant Individuals to Inform Prescription Drug Labeling.
The Journal of Clinical Pharmacology
Volume: 60
Date: 12 2020